| Product Code: ETC7924236 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia saw a surge in viral vector and vaccine import shipments, with top exporters being Metropolitan France, Germany, Lithuania, Poland, and the USA. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the industry experienced a remarkable compound annual growth rate (CAGR) of 43.42% from 2020 to 2024. However, there was a sharp decline in growth rate from 2023 to 2024 at -57.01%. This data underscores the dynamic nature of the market and the importance of monitoring trends to anticipate future developments in the Latvian healthcare sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Viral Vector and Vaccine Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Viral Vector and Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Viral Vector and Vaccine Market - Industry Life Cycle |
3.4 Latvia Viral Vector and Vaccine Market - Porter's Five Forces |
3.5 Latvia Viral Vector and Vaccine Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Latvia Viral Vector and Vaccine Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Latvia Viral Vector and Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development in the healthcare sector |
4.2.2 Rising prevalence of infectious diseases in Latvia |
4.2.3 Government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of viral vector and vaccines |
4.3.2 High costs associated with research, development, and production of vaccines |
4.3.3 Limited awareness and acceptance of vaccination among the population |
5 Latvia Viral Vector and Vaccine Market Trends |
6 Latvia Viral Vector and Vaccine Market, By Types |
6.1 Latvia Viral Vector and Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Viral Vector and Vaccine Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Latvia Viral Vector and Vaccine Market Revenues & Volume, By Adenovirus, 2022 - 2032F |
6.1.4 Latvia Viral Vector and Vaccine Market Revenues & Volume, By Fowlpox Virus, 2022 - 2032F |
6.1.5 Latvia Viral Vector and Vaccine Market Revenues & Volume, By Attenuated Yellow Fever, 2022 - 2032F |
6.1.6 Latvia Viral Vector and Vaccine Market Revenues & Volume, By Vaccinia Virus Vectors, 2022 - 2032F |
6.2 Latvia Viral Vector and Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Viral Vector and Vaccine Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.2.3 Latvia Viral Vector and Vaccine Market Revenues & Volume, By Biopharmaceutical Companies, 2022 - 2032F |
6.2.4 Latvia Viral Vector and Vaccine Market Revenues & Volume, By Others, 2022 - 2032F |
7 Latvia Viral Vector and Vaccine Market Import-Export Trade Statistics |
7.1 Latvia Viral Vector and Vaccine Market Export to Major Countries |
7.2 Latvia Viral Vector and Vaccine Market Imports from Major Countries |
8 Latvia Viral Vector and Vaccine Market Key Performance Indicators |
8.1 Percentage increase in research and development funding for viral vector and vaccine development |
8.2 Number of reported cases of infectious diseases in Latvia |
8.3 Percentage of population covered under government vaccination programs |
9 Latvia Viral Vector and Vaccine Market - Opportunity Assessment |
9.1 Latvia Viral Vector and Vaccine Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Latvia Viral Vector and Vaccine Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Latvia Viral Vector and Vaccine Market - Competitive Landscape |
10.1 Latvia Viral Vector and Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Latvia Viral Vector and Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here